InvestSMART

Antisense Therapeutics Limited (ASX: ANP) - Announcements

Current share price for ANP : $0.058 0.003 (4.92%)+

ASX company news and announcements for Antisense Therapeutics Limited (ANP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Antisense Therapeutics Limited (ANP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Antisense Therapeutics Limited (ANP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Antisense Therapeutics Limited (ANP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Company Appointment 23 Jul 2018 9:10AM $0.027 $0.058 risen by 114.81%
$52 ANP initiates ATL1102 Phase II clinical trial in DMD 16 Jul 2018 9:35AM $0.025 $0.058 risen by 132%
$52 Appendix 3B 28 Jun 2018 3:09PM $0.025 $0.058 risen by 132%
$52 121 Tech Investment Hong Kong Conference Presentation 14 Jun 2018 10:04AM $0.026 $0.058 risen by 123.08%
$52 ATL1103/atesidorsen Early Access Program Progress Update 14 Jun 2018 9:53AM $0.026 $0.058 risen by 123.08%
$52 Change of Director's Interest Notice - WG 1 Jun 2018 11:30AM $0.025 $0.058 risen by 132%
$52 ATL1103 Phase II trial results published in leading journal 23 May 2018 9:56AM $0.027 $0.058 risen by 114.81%
$52 Response to ASX Price & Volume Query 14 May 2018 10:05AM $0.027 $0.058 risen by 114.81%
$52 Ceasing to be a substantial holder from OPT 11 May 2018 4:49PM $0.027 $0.058 risen by 114.81%
$52 Change of Director's Interest Notice - (RM, MD, GP, WG, GM) 9 May 2018 3:44PM $0.026 $0.058 risen by 123.08%
$52 Appendix 3B - Completion of Allotment 9 May 2018 3:35PM $0.026 $0.058 risen by 123.08%
$52 Becoming a substantial holder 9 May 2018 9:50AM $0.026 $0.058 risen by 123.08%
$52 Change in substantial holding from AEF 8 May 2018 3:52PM $0.026 $0.058 risen by 123.08%
$52 Top 20 securityholders 7 May 2018 1:00PM $0.024 $0.058 risen by 141.67%
$52 Appendix 3B 7 May 2018 12:29PM $0.024 $0.058 risen by 141.67%
$52 $5 Million Capital Raising Completion 3 May 2018 3:43PM $0.025 $0.058 risen by 132%
$52 Corporate Presentation 1 May 2018 9:38AM $0.025 $0.058 risen by 132%
$52 Appendix 4C - quarterly 23 Apr 2018 9:56AM $0.026 $0.058 risen by 123.08%
$52 Cleansing Notice 16 Apr 2018 9:28AM $0.029 $0.058 risen by 100%
$52 Becoming a substantial holder from AEF 10 Apr 2018 4:58PM $0.032 $0.058 risen by 81.25%
$52 Letter to Optionholders 6 Apr 2018 10:14AM $0.030 $0.058 risen by 93.33%
$52 Letters to Shareholders and Optionholders 6 Apr 2018 9:53AM $0.030 $0.058 risen by 93.33%
$52 Cleansing Notice 6 Apr 2018 9:49AM $0.030 $0.058 risen by 93.33%
$52 Entitlement Offer Booklet 6 Apr 2018 9:46AM $0.030 $0.058 risen by 93.33%
$52 Appendix 3B 6 Apr 2018 9:36AM $0.030 $0.058 risen by 93.33%

326 - 350 of 707 results

Page 14 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.